과제정보
We would like to express sincere gratitude to patients and their families who inspire and motivate us. We are indebted to our colleagues in Departments of Pathology, Nuclear Medicine, Gynecology Oncology and Radiation Oncology, for their in-depth discussions on weekly multidisciplinary tumor board.
참고문헌
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30
- Global Cancer Observatory. International Agency for Research on Cancer (IARC) web site. http://globocan.iarc.fr/. Published 2014. Accessed May 11, 2018
- Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs, Volume 6, 4th ed. Geneva: World Health Organization, 2014:141-145
- D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol 2010;116:131-139
- Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. Uterine neoplasms, Version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2018;16:170-199
- Patel-Lippmann K, Robbins JB, Barroilhet L, Anderson B, Sadowski EA, Boyum J. MR imaging of cervical cancer. Magn Reson Imaging Clin N Am 2017;25:635-649
- Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 2013;266:717-740
- Padhani AR, Koh DM, Collins DJ. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 2011;261:700-718
- Leach MO, Morgan B, Tofts PS, Buckley DL, Huang W, Horsfield MA, et al.; Experimental Cancer Medicine Centres Imaging Network Steering Committee. Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol 2012;22:1451-1464
- Goto A, Takeuchi S, Sugimura K, Maruo T. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 2002;12:354-361
- Lin G, Lin YC, Wu RC, Yang LY, Lu HY, Tsai SY, et al. Developing and validating a multivariable prediction model to improve the diagnostic accuracy in determination of cervical versus endometrial origin of uterine adenocarcinomas: a prospective MR study combining diffusion-weighted imaging and spectroscopy. J Magn Reson Imaging 2018;47:1654-1666
- Cornfeld D, Israel G, Martel M, Weinreb J, Schwartz P, McCarthy S. MRI appearance of mesenchymal tumors of the uterus. Eur J Radiol 2010;74:241-249
- Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994;83:414-418
- Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 2003;89:460-469
- Wu TI, Yen TC, Lai CH. Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol 2011;25:681-689
- Lakhman Y, Veeraraghavan H, Chaim J, Feier D, Goldman DA, Moskowitz CS, et al. Differentiation of uterine leiomyosarcoma from atypical leiomyoma: diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis. Eur Radiol 2017;27:2903-2915
- Shah SH, Jagannathan JP, Krajewski K, O'Regan KN, George S, Ramaiya NH. Uterine sarcomas: then and now. AJR Am J Roentgenol 2012;199:213-223
- Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging 2004;20:998-1007
- Thomassin-Naggara I, Dechoux S, Bonneau C, Morel A, Rouzier R, Carette MF, et al. How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol 2013;23:2306-2314
- Tamai K, Koyama T, Saga T, Morisawa N, Fujimoto K, Mikami Y, et al. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2008;18:723-730
- Namimoto T, Yamashita Y, Awai K, Nakaura T, Yanaga Y, Hirai T, et al. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2009;19:2756-2764
- Ueda H, Togashi K, Konishi I, Kataoka ML, Koyama T, Fujiwara T, et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics 1999;19 Spec No:S131-S145
- Hricak H, Tscholakoff D, Heinrichs L, Fisher MR, Dooms GC, Reinhold C, et al. Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. Radiology 1986;158:385-391
- Lin G, Yang LY, Huang YT, Ng KK, Ng SH, Ueng SH, et al. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma. J Magn Reson Imaging 2016;43:333-342
- Li HM, Liu J, Qiang JW, Zhang H, Zhang GF, Ma F. Diffusion-weighted imaging for differentiating uterine leiomyosarcoma from degenerated leiomyoma. J Comput Assist Tomogr 2017;41:599-606
- Sato K, Yuasa N, Fujita M, Fukushima Y. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol 2014;210:368.e1-e368.e8
- Trope CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol 2012;51:694-705
- Tse KY, Crawford R, Ngan HY. Staging of uterine sarcomas. Best Pract Res Clin Obstet Gynaecol 2011;25:733-749
- Gadducci A, Cosio S, Romanini A, Genazzani AR. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 2008;65:129-142
- Tirumani SH, Ojili V, Shanbhogue AK, Fasih N, Ryan JG, Reinhold C. Current concepts in the imaging of uterine sarcoma. Abdom Imaging 2013;38:397-411
- Furukawa R, Akahane M, Yamada H, Kiryu S, Sato J, Komatsu S, et al. Endometrial stromal sarcoma located in the myometrium with a low-intensity rim on T2-weighted images: report of three cases and literature review. J Magn Reson Imaging 2010;31:975-979
- Koyama T, Togashi K, Konishi I, Kobayashi H, Ueda H, Kataoka ML, et al. MR imaging of endometrial stromal sarcoma: correlation with pathologic findings. AJR Am J Roentgenol 1999;173:767-772
- Ueda M, Otsuka M, Hatakenaka M, Sakai S, Ono M, Yoshimitsu K, et al. MR imaging findings of uterine endometrial stromal sarcoma: differentiation from endometrial carcinoma. Eur Radiol 2001;11:28-33
- Boskovic V, Bozanovic T, Ljubic A, Likic-Ladjevic I, Janjic T, Milicevic S. Endometrial stromal sarcoma with intracaval extension at initial presentation. Eur J Gynaecol Oncol 2013;34:280-281
- Huang YL, Huang YT, Ng KK, Lai CH, Lin G. Differentiating low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma by using magnetic resonance imaging, Abstract No. ESGO7-0441. Proceeding of International Meeting of the European Society of Gynaecological Oncology;2017 November 4-7;Vienna, Austria
- Santos P, Cunha TM. Uterine sarcomas: clinical presentation and MRI features. Diagn Interv Radiol 2015;21:4-9
- Arend R, Bagaria M, Lewin SN, Sun X, Deutsch I, Burke WM, et al. Long-term outcome and natural history of uterine adenosarcomas. Gynecol Oncol 2010;119:305-308
- Takeuchi M, Matsuzaki K, Yoshida S, Kudo E, Bando Y, Hasebe H, et al. Adenosarcoma of the uterus: magnetic resonance imaging characteristics. Clin Imaging 2009;33:244-247
- Yoshizako T, Wada A, Kitagaki H, Ishikawa N, Miyazaki K. MR imaging of uterine adenosarcoma: case report and literature review. Magn Reson Med Sci 2011;10:251-254
- Barral M, Place V, Dautry R, Bendavid S, Cornelis F, Foucher R, et al. Magnetic resonance imaging features of uterine sarcoma and mimickers. Abdom Radiol (NY) 2017;42:1762-1772
- Artioli G, Wabersich J, Ludwig K, Gardiman MP, Borgato L, Garbin F. Rare uterine cancer: carcinosarcomas. Review from histology to treatment. Crit Rev Oncol Hematol 2015;94:98-104
- Arend R, Doneza JA, Wright JD. Uterine carcinosarcoma. Curr Opin Oncol 2011;23:531-536
- Menczer J. Review of recommended treatment of uterine carcinosarcoma. Curr Treat Options Oncol 2015;16:53
- Lewin SN. Revised FIGO staging system for endometrial cancer. Clin Obstet Gynecol 2011;54:215-218
- Beddy P, Moyle P, Kataoka M, Yamamoto AK, Joubert I, Lomas D, et al. Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 2012;262:530-537
- Lin G, Ng KK, Chang CJ, Wang JJ, Ho KC, Yen TC, et al. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience. Radiology 2009;250:784-792
- Bharwani N, Newland A, Tunariu N, Babar S, Sahdev A, Rockall AG, et al. MRI appearances of uterine malignant mixed mullerian tumors. AJR Am J Roentgenol 2010;195:1268-1275
- Genever AV, Abdi S. Can MRI predict the diagnosis of endometrial carcinosarcoma? Clin Radiol 2011;66:621-624
- Tanaka YO, Tsunoda H, Minami R, Yoshikawa H, Minami M. Carcinosarcoma of the uterus: MR findings. J Magn Reson Imaging 2008;28:434-439
- Takeuchi M, Matsuzaki K, Harada M. Carcinosarcoma of the uterus: MRI findings including diffusion-weighted imaging and MR spectroscopy. Acta Radiol 2016;57:1277-1284
- Kato H, Kanematsu M, Furui T, Imai A, Hirose Y, Kondo H, et al. Carcinosarcoma of the uterus: radiologic-pathologic correlations with magnetic resonance imaging including diffusion-weighted imaging. Magn Reson Imaging 2008;26:1446-1450
- Hernandez Mateo P, Mendez Fernandez R, Serrano Tamayo E. Uterine sarcoma vs adenocarcinoma: can MRI distinguish between them? Radiologia 2016;58:199-206
- Huang YT, Chang CB, Yeh CJ, Lin G, Huang HJ, Wang CC, et al. Diagnostic accuracy of 3.0T diffusion-weighted MRI for patients with uterine carcinosarcoma: assessment of tumor extent and lymphatic metastasis. J Magn Reson Imaging 2018;48:622-631
- Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998;280:1510-1517
- Felix AS, Weissfeld JL, Stone RA, Bowser R, Chivukula M, Edwards RP, et al. Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control 2010;21:1851-1856
- Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet 2015;131 Suppl 2:S96-S104
- Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 2009;105:109
- Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999;212:711-718
- Fujii S, Kido A, Baba T, Fujimoto K, Daido S, Matsumura N, et al. Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging. Eur J Radiol 2015;84:581-589
- Andreano A, Rechichi G, Rebora P, Sironi S, Valsecchi MG, Galimberti S. MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis. Eur Radiol 2014;24:1327-1338
- Ota T, Hori M, Onishi H, Sakane M, Tsuboyama T, Tatsumi M, et al. Preoperative staging of endometrial cancer using reduced field-of-view diffusion-weighted imaging: a preliminary study. Eur Radiol 2017;27:5225-5235
- Takeuchi M, Matsuzaki K, Harada M. Evaluating myometrial invasion in endometrial cancer: comparison of reduced field-of-view diffusion-weighted imaging and dynamic contrast-enhanced MR imaging. Magn Reson Med Sci 2018;17:28-34
- Bhosale P, Ma J, Iyer R, Ramalingam P, Wei W, Soliman P, et al. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging 2016;43:316-324
- Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE. Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol 2011;205:103-110
- Lin G, Huang YT, Chao A, Ng KK, Yang LY, Ng SH, et al. Influence of menopausal status on diagnostic accuracy of myometrial invasion in endometrial cancer: diffusion-weighted and dynamic contrast-enhanced MRI at 3 T. Clin Radiol 2015;70:1260-1268
- Turan T, Hizli D, Yilmaz SS, Gundogdu B, Boran N, Tulunay G, et al. What is the impact of cervical invasion on lymph node metastasis in patients with stage IIIC endometrial cancer? Arch Gynecol Obstet 2012;285:1119-1124
- Haldorsen IS, Berg A, Werner HM, Magnussen IJ, Helland H, Salvesen OO, et al. Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. Gynecol Oncol 2012;126:413-418
- Luomaranta A, Leminen A, Loukovaara M. Magnetic resonance imaging in the assessment of high-risk features of endometrial carcinoma: a meta-analysis. Int J Gynecol Cancer 2015;25:837-842
- Freeman SJ, Aly AM, Kataoka MY, Addley HC, Reinhold C, Sala E. The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics 2012;32:1805-1827
- Lin G, Huang YT, Chao A, Lin YC, Yang LY, Wu RC, et al. Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T. Eur Radiol 2017;27:1867-1876
- Tamai K, Koyama T, Saga T, Umeoka S, Mikami Y, Fujii S, et al. Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007;26:682-687
- Nougaret S, Reinhold C, Alsharif SS, Addley H, Arceneau J, Molinari N, et al. Endometrial cancer: combined MR volumetry and diffusion-weighted imaging for assessment of myometrial and lymphovascular invasion and tumor grade. Radiology 2015;276:797-808
- Cao K, Gao M, Sun YS, Li YL, Sun Y, Gao YN, et al. Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness. Eur J Radiol 2012;81:1926-1930
- Shih IL, Yen RF, Chen CA, Chen BB, Wei SY, Chang WC, et al. Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: correlation with pathological prognostic factors. J Magn Reson Imaging 2015;42:1723-1732
- Zhang J, Cai S, Li C, Sun X, Han X, Yang C, et al. Can magnetic resonance spectroscopy differentiate endometrial cancer? Eur Radiol 2014;24:2552-2560
- Han X, Kang J, Zhang J, Xiu J, Huang Z, Yang C, et al. Can the signal-to-noise ratio of choline in magnetic resonance spectroscopy reflect the aggressiveness of endometrial cancer? Acad Radiol 2015;22:453-459
- Ueno Y, Forghani B, Forghani R, Dohan A, Zeng XZ, Chamming's F, et al. Endometrial carcinoma: MR imaging-based texture model for preoperative risk stratification-A preliminary analysis. Radiology 2017;284:748-757
- Brown AP, Gaffney DK, Dodson MK, Soisson AP, Belnap TW, Alleman K, et al. Survival analysis of endometrial cancer patients with positive lymph nodes. Int J Gynecol Cancer 2013;23:861-868
- Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95 Suppl 1:S105-S143
- ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-136
- Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:1707-1716
- Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010;375:1165-1172
- Eggemann H, Ignatov T, Kaiser K, Burger E, Costa SD, Ignatov A. Survival advantage of lymphadenectomy in endometrial cancer. J Cancer Res Clin Oncol 2016;142:1051-1060
- Lin G, Ho KC, Wang JJ, Ng KK, Wai YY, Chen YT, et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 2008;28:128-135
- Park JY, Kim EN, Kim DY, Suh DS, Kim JH, Kim YM, et al. Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 2008;108:486-492
- Lai CH, Lin G, Yen TC, Liu FY. Molecular imaging in the management of gynecologic malignancies. Gynecol Oncol 2014;135:156-162
- Lee HJ, Park JY, Lee JJ, Kim MH, Kim DY, Suh DS, et al. Comparison of MRI and 18F-FDG PET/CT in the preoperative evaluation of uterine carcinosarcoma. Gynecol Oncol 2016;140:409-414
- Stecco A, Buemi F, Cassara A, Matheoud R, Sacchetti GM, Arnulfo A, et al. Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases. Radiol Med 2016;121:537-545